目的探讨原发性获得性寒冷性荨麻疹的组胺释放活性。
Objective To evaluate the serum histamine-releasing activity of patients with primary acquired cold urticaria (PACU).
将70例寒冷性荨麻疹患者，随机分2组进行对比观察。
Randomly divide 70 cases of cold urticaria patients into 2 groups and make observation and comparison.
结论：咪唑斯汀治疗原发性获得性寒冷性荨麻疹安全、有效。
Conclusion: the results suggest that mizolastine may be effective and safe in the treatment of primary acquired cold urticaria.
结论：咪唑斯汀治疗原发性获得性寒冷性荨麻疹安全、有效。
Conclusion: the results suggest that mizolastine may be effective and safe in the treatment of primary acquired cold urticaria.
应用推荐